NPT
BIIB icon

Nixon Peabody Trust’s Biogen BIIB Stock Holding History

Nixon Peabody Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-7,186
Closed -$1.7M – 80
2019
Q1 		$1.7M Buy
7,186
+637
+10% +$201K 1.11% 40
2018
Q4 		$1.97M Buy
6,549
+41
+0.6% +$13.1K 1.55% 30
2018
Q3 		$2.3M Sell
6,508
-253
-4% -$87.1K 1.57% 32
2018
Q2 		$1.96M Buy
6,761
+240
+4% +$67.5K 1.52% 31
2018
Q1 		$1.79M Buy
6,521
+157
+2% +$48.7K 1.6% 32
2017
Q4 		$2.03M Buy
6,364
+130
+2% +$41.7K 1.75% 31
2017
Q3 		$1.95M Buy
6,234
+55
+0.9% +$16.3K 1.77% 29
2017
Q2 		$1.68M Buy
6,179
+120
+2% +$31.7K 1.55% 32
2017
Q1 		$1.66M Buy
6,059
+115
+2% +$32.5K 1.56% 34
2016
Q4 		$1.69M Buy
5,944
+485
+9% +$144K 1.64% 30
2016
Q3 		$1.71M Buy
5,459
+46
+0.8% +$13.6K 1.68% 27
2016
Q2 		$1.31M Buy
+5,413
New +$1.43M 1.14% 38

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nixon Peabody Trust's BIIB Position: Q2 2019 in Review

Nixon Peabody Trust sold out of Biogen (BIIB) in Q2 2019, closing a stake of 7,186 shares — an estimated $1.7M sold.

Nixon Peabody Trust first reported a position in BIIB in Q2 2016 and held it in 12 quarters. The position peaked at $2.3M in Q3 2018. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Nixon Peabody Trust reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Nixon Peabody Trust sold 7,186 Biogen shares in Q2 2019, an estimated $1.7M.
  • Nixon Peabody Trust first reported a position in Biogen in Q2 2016 and held it in 12 quarters.
  • Nixon Peabody Trust's Biogen position peaked at $2.3M in Q3 2018.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Nixon Peabody Trust's 13F filing for Q2 2019, filed 1 Aug 2019.